C-PATH.ORG: Keyword Density Checker

Total words: 2691 | 2-word phrases: 688 | 3-word phrases: 778 | 4-word phrases: 831

PAGE INFO

Title	Try to keep the title under 60 characters (62 characters) Critical Path Institute - The Path Forward in Drug Development
Description	Try to keep the meta description between 50 - 160 characters (159 characters) C-Path (Critical Path Institute) optimizes drug and medical product development lifecycles by convening pharma, government, patient and academic organizations.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	No H1 tag on the page (0 characters)

#	Keyword	Frequency	Density
1	clinical trial design	10	1.29%
2	optimize clinical trial	8	1.03%
3	trial enrichment tool	7	0.90%
4	help optimize clinical	6	0.77%
5	clinical trial enrichment	5	0.64%
6	regulators pharmaceutical and	5	0.64%
7	pharmaceutical and biotech	4	0.51%
8	design in the	4	0.51%
9	unites regulators pharmaceutical	4	0.51%
10	trial design in	4	0.51%
11	patient advocates to	4	0.51%
12	and patient advocates	4	0.51%
13	to advance drug	4	0.51%
14	enrichment tool to	4	0.51%
15	advance drug development	4	0.51%
16	quantitative clinical trial	4	0.51%
17	a quantitative clinical	4	0.51%
18	disease outcomes consortium	3	0.39%
19	outcomes consortium database	3	0.39%
20	polycystic kidney disease	3	0.39%
21	to help optimize	3	0.39%
22	tool to help	3	0.39%
23	and safety sciences	3	0.39%
24	kidney disease outcomes	3	0.39%
25	program unites regulators	3	0.39%
26	drug development and	3	0.39%
27	duchenne muscular dystrophy	3	0.39%
28	and biotech companies	3	0.39%
29	trial simulation tool	3	0.39%
30	clinical trial simulation	3	0.39%

#	Keyword	Frequency	Density
1	optimize clinical trial design	8	0.96%
2	help optimize clinical trial	6	0.72%
3	clinical trial enrichment tool	5	0.60%
4	and patient advocates to	4	0.48%
5	regulators pharmaceutical and biotech	4	0.48%
6	unites regulators pharmaceutical and	4	0.48%
7	trial design in the	4	0.48%
8	clinical trial design in	4	0.48%
9	to advance drug development	3	0.36%
10	trial enrichment tool to	3	0.36%
11	advocates to advance drug	3	0.36%
12	advance drug development and	3	0.36%
13	program unites regulators pharmaceutical	3	0.36%
14	kidney disease outcomes consortium	3	0.36%
15	disease outcomes consortium database	3	0.36%
16	a quantitative clinical trial	3	0.36%
17	tool to help optimize	3	0.36%
18	pharmaceutical and biotech companies	3	0.36%
19	to help optimize clinical	3	0.36%
20	clinical trial simulation tool	3	0.36%
21	prevent or delay diagnosis	2	0.24%
22	of t1d using islet	2	0.24%
23	diagnosis of t1d using	2	0.24%
24	delay diagnosis of t1d	2	0.24%
25	or delay diagnosis of	2	0.24%
26	earlymotor stages of parkinson’s	2	0.24%
27	stages of parkinson’s disease	2	0.24%
28	tbplatform was created for	2	0.24%
29	tool helps optimize clinical	2	0.24%
30	enrichment tool helps optimize	2	0.24%
31	of preclinical experiments’ data	2	0.24%
32	the tbplatform was created	2	0.24%
33	was created for the	2	0.24%
34	helps optimize clinical trial	2	0.24%
35	deidentified and compliant to	2	0.24%
36	by the data owners	2	0.24%
37	clinical trial design of	2	0.24%
38	clinical trial design for	2	0.24%
39	for mild and moderate	2	0.24%
40	mild and moderate ad	2	0.24%

#	URL	Whois	Check
1	https://donate.stripe.com/4gw14D20OgDeag88ww	Whois	stripe.com